(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. An oocyte is specified in
oskA87/Df(3R)pXT103. (A,B)
Whole mount antibody staining of
oskA87/Df(3R)pXT103 ovaries (B) shows that
Staufen is not enriched in the oskA87mRNA null oocytes
compared with wild type (A). (C-J) In contrast, the oocyte markers BicD
(Suter and Steward, 1991), Orb
(Lantz et al., 1994), Bruno
(Webster et al., 1997), and
Par-1 (Shulman et al., 2000;
Tomancak et al., 2000)
accumulate in a single, posterior cell in both wild-type (C,E,G,I) and
oskA87/Df(3R)pXT103 (D,F,H,J) egg chambers,
indicating that early steps in oocyte specification occur normally in the
mutant. (K,L) DAPI staining of chromatin in stage 4 wild-type
(K) and oskA87/Df(3R)pXT103 (L) egg chambers.
The compact structure of the karyosome (arrow) is detected within the
wild-type oocyte nucleus. oskA87/Df(3R)pXT103
mutant oocytes show a fragmented karyosome structure (arrow).